Cymabay stock news
WebJan 30, 2024 · CymaBay sold 11,821,428 shares of its common stock in the offering, including 1,821,428 shares pursuant to the full exercise of the underwriters’ option to purchase additional shares, at a... WebMay 21, 2024 · $848M Today's Change (-2.90%) -$0.26 Current Price $8.72 Price as of March 31, 2024, 4:00 p.m. ET A do-over on one of its drugs is a potential game-changer for CymaBay. Shares of CymaBay...
Cymabay stock news
Did you know?
WebThe latest price target for CymaBay Therapeutics ( NASDAQ: CBAY) was reported by HC Wainwright & Co. on Monday, March 20, 2024. The analyst firm set a price target for 12.00 expecting CBAY to... WebStock analysis for Cymabay Therapeutics Inc (CBAY:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
WebApr 6, 2024 · Piper Sandler increased their price objective on CymaBay Therapeutics from $12.00 to $19.00 and gave the stock an overweight rating in a report on Sunday, January 29th. WebSep 5, 2024 · Earnings Estimate Revisions for CymaBay Therapeutics Inc. For the fiscal year ending December 2024, this company is expected to earn -$1.21 per share, which is a change of 4.7% from the year-ago...
WebStock Information Company Information CymaBay Therapeutics 7575 Gateway Blvd Suite 110 Newark, CA 94560 Investor Relations LifeSci Advisors, LLC Hans Vitzthum (617) 430-7578 [email protected] Recent News 16 Mar CymaBay Reports Fourth Quarter and Year Ended December 31, 2024 Financial Results and Provides Corporate Update 9 … WebJan 24, 2024 · CymaBay Therapeutics Inc (NASDAQ:CBAY) shares are trading higher by 9.30% to $7.22 Tuesday morning. The company priced a public offering of common …
WebFind the latest news headlines from CymaBay Therapeutics Inc. Common Stock (CBAY) at Nasdaq.com. CymaBay Therapeutics Inc. Common Stock (CBAY) News Headlines …
WebFeb 8, 2024 · In the last 3 months, 4 analysts have offered 12-month price targets for CymaBay Therapeutics. The company has an average price target of $15.25 with a high … gmib 7 year lockWebView the latest CymaBay Therapeutics Inc. (CBAY) stock price, news, historical charts, analyst ratings and financial information from WSJ. CBAY CymaBay Therapeutics Inc. … bombay chai teaWebApr 6, 2024 · CymaBay Therapeutics (Nasdaq:CBAY) - Stock Price, News & Analysis - Simply Wall St Stocks / United States / Pharmaceuticals & Biotech CymaBay Therapeutics NasdaqGS:CBAY Stock Report Last Price US$8.72 Market Cap US$848.4m 7D 3.0% 1Y 166.7% Updated 31 Mar, 2024 Data Company Financials + 8 Analysts CBAY Stock … gmib annual withdrawal amountWebAug 2, 2024 · NEWARK, Calif., Aug. 02, 2024 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic... gmi basketball tournament houstonWebMar 29, 2024 · Contacts: Sujal Shah CymaBay Therapeutics, Inc. (510) 293-8800 [email protected] Markets Insider and Business Insider Editorial Teams were not involved in the creation of this post. SHARE THIS POST bombay central temple texasWebMar 29, 2024 · A price increase of 10.3% over the past four weeks ensures that the trend is still in place for the stock of this company. Moreover, CBAY is currently trading at 85.3% of its 52-week High-Low... gmi building groupWebCymaBay Therapeutics Shares Jump on Pricing of Offering Jan. 24, 2024 at 8:49 a.m. ET CymaBay Therapeutics stock price target cut to $8 from $10 at B. Riley May. 18, 2024 … bombay chamber of commerce and industry